全身11C-PIB PET/CT显像系统性淀粉样变性:心脏淀粉样变性中的器官间连接对预后意义
回顾性分析70例经活检分组的患者(心脏淀粉样变性31例、非心脏淀粉样变性12例、无淀粉样变性对照27例),采用11C-PIB PET/CT及自动分割提取SUVmean。心脏淀粉样变性患者心肌、肝、肾淀粉样沉积显著,脑-器官连接(尤其后扣带回皮层、顶叶与心肌负荷间)及器官间连接显著增强,死亡率更高;系统性心脏淀粉样变性组骨髓、肺、脾沉积与死亡率升高强相关。
要点
- 心脏淀粉样变性患者心肌、肝、肾SUVmean升高,提示多器官淀粉样沉积。
- 后扣带回皮层、顶叶与心肌淀粉样负荷间存在显著脑-器官连接。
- 系统性心脏淀粉样变性组骨髓、肺、脾沉积与死亡率升高强相关。
核心结论
- 心脏淀粉样变性患者存在广泛的系统性受累,表现为显著的脑-器官及器官间连接模式。
- 心脏淀粉样变性显著影响生存,尤其当合并骨髓、肺、脾淀粉样沉积时,提示需要全面的诊断和管理方法。
研究设计与样本
- 回顾性分析70例经活检分组的患者:心脏淀粉样变性31例、非心脏淀粉样变性12例、无淀粉样变性对照27例。
- 行11C-PIB PET/CT扫描,采用自动分割技术提取SUVmean,用Spearman相关分析脑-器官、脑-脑及器官-器官连接。
- 采用Kaplan–Meier分析评估生存结局及预后因素。
主要发现
- 心脏淀粉样变性患者心肌、肝、肾淀粉样沉积显著,SUVmean值升高。
- 观察到显著的脑-器官连接,尤其在后扣带回皮层、顶叶与心肌淀粉样负荷之间。
- 心脏淀粉样变性患者器官间连接明显更强,提示系统性受累;非心脏淀粉样变性和无淀粉样变性对照患者脑-器官及器官间相互作用较弱。
- 心脏淀粉样变性组死亡率更高,尤其在系统性心脏淀粉样变性组;该组骨髓、肺、脾淀粉样沉积升高与死亡率增加强相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Amyloidosis is a systemic disorder characterized by amyloid fibril deposition in multiple organs, including the heart, brain, liver, kidneys, and lungs, leading to organ dysfunction and affecting survival. In cardiac amyloidosis (CA), where the heart is primarily affected, the broader impact on other organs, particularly the brain, is not fully understood. This study aimed to assess the extent of amyloid deposition across systemic organs in CA, investigate brain-organ, brain-brain and organ-organ connections, and evaluate their effects on patients’ survival. METHODS: A retrospective analysis was conducted on 70 patients, categorized into three groups by biopsy: cardiac amyloidosis (CA) (n = 31), non-cardiac amyloidosis (non-CA) (n = 12), and no amyloidosis control (NC) (n = 27). 11C-PIB PET/CT scans were performed, and standard uptake value mean (SUVmean) values were extracted using automated segmentation techniques. Brain-organ, brain-brain, organ-organ connectivity analyses were conducted using Spearman correlation. Survival outcomes and prognostic factors were evaluated using Kaplan–Meier analysis. RESULTS: Amyloid deposition in CA patients was prominent in the myocardium, liver, and kidneys, reflected by increased SUVmean values. Significant brain-organ connectivity was observed, particularly between the posterior cingulate cortex (PCC), parietal lobes, and myocardial amyloid burden. Additionally, CA patients demonstrated markedly stronger inter-organ connectivity, indicating systemic involvement. In contrast, Non-CA and NC patients demonstrated weaker brain-organ and inter-organ interactions. The CA group exhibited a higher mortality rate, highlighting the severe prognosis, particularly in systemic CA (SCA). Furthermore, elevated amyloid deposition in the bone marrow, lungs and spleen within SCA group was strongly associated with increased mortality. CONCLUSION: In CA patients, amyloidosis was associated with extensive systemic involvement, as shown by significant brain-organ and inter-organ connectivity patterns. Findings emphasize that cardiac amyloidosis substantially impacts survival, particularly when accompanied by amyloid deposition in the bone marrow, lungs, and spleen, indicating the need for a comprehensive diagnostic and management approach. CLINICAL TRIAL NUMBER: Not applicable.
引用
- Hong Z, Xue S, Yu J, et al. Total-body 11C-PIB PET/CT imaging of systemic amyloidosis: inter-organ connectivity in cardiac amyloidosis for prognostic insights. Eur J Nucl Med Mol Imaging. 2025. PMID: 40323422. doi:10.1007/s00259-025-07308-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。